This case highlights the value of transcript-level functional assays for interpreting PTCH1 splice-site variants and supports individualized, toxicity-guided sonidegib scheduling in selected patients with Gorlin-Goltz syndrome. The gene discussed is PTCH1; the disease is nevoid basal cell carcinoma syndrome.